ArticlePharmacoEconomics2015
Choice of Outcome Measure in an Economic Evaluation: A Potential Role for the Capability Approach.
Article in PharmacoEconomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- The impact of health vs. non-health goals on individuals' lifestyle program choices: a discrete choice experiment approach.BMC public health · 2020Trial
- Developing French Population Tariffs for the ICECAP-A Using Best-Worst Scaling.PharmacoEconomics · 2026Article
- Conceptualising 'Benefits Beyond Health' in the Context of the Quality-Adjusted Life-Year: A Critical Interpretive Synthesis.PharmacoEconomics · 2021Review
- Integration of Conversion Factors for the Development of an Inclusive eHealth Tool With Caregivers of Functionally Dependent Older Persons: Social Justice Design.JMIR human factors · 2020Article
- Capability instruments in economic evaluations of health-related interventions: a comparative review of the literature.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2020Review
- Evaluation as institution: a contractarian argument for needs-based economic evaluation.BMC medical ethics · 2018Article
- Raise the Bar, Not the Threshold Value: Meeting Patient Preferences for Palliative and End-of-Life Care.PharmacoEconomics - open · 2018Article
- Adaptation and assessments of the Chinese version of the ICECAP-A measurement.Health and quality of life outcomes · 2018Article
- Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Opportunities and Challenges.Applied health economics and health policy · 2017Article
- An Investigation of the Overlap Between the ICECAP-A and Five Preference-Based Health-Related Quality of Life Instruments.PharmacoEconomics · 2017Article
- Are Quality-Adjusted Life Years a Good Proxy Measure of Individual Capabilities?PharmacoEconomics · 2017Article
- EQ-5D and the EuroQol Group: Past, Present and Future.Applied health economics and health policy · 2017Review
- From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare.PharmacoEconomics · 2016Article
- Applications of the Capability Approach in the Health Field: A Literature Review.Social indicators researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The last decade has seen a renewed interest in Sen's capability approach; health economists have been instrumental in leading much of this work. One particular stream of research is the application of the approach to outcome measurement. To date, there have been a dozen attempts (some combined) to operationalise the approach, and produce an outcome measure that offers a broader evaluative space than health-related quality-of-life measures. Applications have so far been confined to public health, physical, mental health and social care interventions, but the capability approach could be of benefit to evaluations of pharmacotherapies and other technologies. This paper provides an introduction to the capability approach, reviews the measures that are available for use in an economic evaluation, including their current applications, and then concludes with a discussion of a number of issues that require further consideration before the approach is adopted more widely to inform resource allocation decisions.
Indexed as
Identifiers
25862464What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.